| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212438 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 24 Pages |
Abstract
We found that HDREBT after EBRT results in a high overall response rate, with improved L-PFS for patients with a CR. The high observed rate of severe late toxicity requires further evaluation of the risks and benefits of an HDREBT boost.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eva C. MD, Annemieke MD, PhD, Remi A. MD, PhD, Desiree H.J.G. MD, PhD, Martijn PhD, Jeroen MD, PhD, Tom MD, Jan-Huib MD, Laura A. MD, Baukelien MD, PhD, Corrie A.M. MD, PhD,